FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. completed its business combination with Delwinds Insurance Acquisition Corp. (NYSE American: DWIN), a blank-check company sponsored by Delwinds Capital LLC that priced its initial public offering in 2021 with a focus on the insurance sector. The September 2022 8-K filing with the SEC marked a key step in the de-SPAC transaction, after which the combined company began trading on NYSE American under the ticker FOXO. FOXO Technologies develops epigenetic biomarker science applied to life insurance underwriting, occupying a niche at the crossroads of longevity research and insurtech. Sign up at SpacDesk for full filings, deal timelines, and deep data on this transaction and hundreds of other SPAC combinations.